We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

454 Life Sciences and Roche NimbleGen Announce Collaboration with Eli Lilly and SeqWright

News   Aug 04, 2009

 
454 Life Sciences and Roche NimbleGen Announce Collaboration with Eli Lilly and SeqWright
 
 
Advertisement
 

RELATED ARTICLES

Key Genetic Similarities Put Apes and Some Monkeys at Risk of COVID-19

News

Non-human primates could be highly susceptible to infection by SARS-CoV-2 according to a newly published study. This potential risk is of concern to primatologists around the world working with wild and captive primates.

READ MORE

Biomarkers Could Be Used in Quick COVID-19 Blood Screening Strategy

News

A new study suggests that COVID-19 affects the human body’s blood concentration levels of specific metabolites. Three metabolites identified in the study could act as biomarkers and hold potential to be measured through an inexpensive blood test to quickly screen patients for the disease.

READ MORE

How a Genetic Mutation Leads to “Night Owl” Sleep Disorder

News

A new study by researchers at UC Santa Cruz shows how a genetic mutation throws off the timing of the biological clock, causing a common sleep syndrome called delayed sleep phase disorder.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE